Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.

× No keyword cloud information.

11 in total

1. Should erythropoiesis-stimulating agents be used in predialysis patients?

Authors: Rene Breault
Journal: Can J Hosp Pharm Date: 2011-03

2. Standards of clinical practice for renal pharmacists.

Authors: Colette B Raymond; Lori D Wazny; Amy R Sood
Journal: Can J Hosp Pharm Date: 2013-11

3. The new FDA labeling for ESA--implications for patients and providers.

Authors: Braden J Manns; Marcello Tonelli
Journal: Clin J Am Soc Nephrol Date: 2012-01-19 Impact factor: 8.237

4. Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres.

Authors: Jessica Jordan; Joanne Breckles; Valerie Leung; Maryann Hopkins; Marisa Battistella
Journal: Can J Hosp Pharm Date: 2012-11

Review 5. Iron Therapy Challenges for the Treatment of Nondialysis CKD Patients.

Authors: Francesco Locatelli; Sandro Mazzaferro; Jerry Yee
Journal: Clin J Am Soc Nephrol Date: 2016-05-16 Impact factor: 8.237

6. Parenteral versus oral iron therapy for adults and children with chronic kidney disease.

Authors: Emma L O'Lone; Elisabeth M Hodson; Ionut Nistor; Davide Bolignano; Angela C Webster; Jonathan C Craig
Journal: Cochrane Database Syst Rev Date: 2019-02-21

7. Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis.

Authors: Paulo D Picon; Suzane Cristina M Pribbernow; Carlos A Prompt; Suzana C Schacher; Veronica V H Antunes; Bianca P Mentz; Fabiane L Oliveira; Celia Mariana B de Souza; Fernando C Schacher
Journal: Clinics (Sao Paulo) Date: 2014-08 Impact factor: 2.365

8. A budget impact analysis of the introduction of erythropoiesis stimulating agent subsequent entry biologics for the treatment of anemia of chronic kidney disease in Canada.

Authors: Nicole W Tsao; Clifford Lo; Marianna Leung; Judith G Marin; Dan Martinusen
Journal: Can J Kidney Health Dis Date: 2014-11-11

9. Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial.

Authors: Andrea L Woodland; Sean W Murphy; Bryan M Curtis; Brendan J Barrett
Journal: Can J Kidney Health Dis Date: 2017-06-30

10. Maintaining over time clinical performance targets on anaemia correction in unselected population on chronic dialysis at 20 Italian centres. Data from a retrospective study for a clinical audit.

Authors: Silvia Soffritti; Giorgia Russo; Stefano Cantelli; Giuseppe Gilli; Luigi Catizone
Journal: BMC Nephrol Date: 2009-10-24 Impact factor: 2.388